Latest Options News

Page 5 of 782
Laramide Resources reported a C$4.20 million unaudited net loss for the nine months to September 30, 2026, more than double the prior-year loss, while cash fell to C$2.19 million. The uranium explorer continued expanding its mineral portfolio, but funded that activity through a C$5.01 million placement and additional debt.
Maxwell Dee
Maxwell Dee
16 Nov 2026
Besra Gold reported a US$3.96 million quarterly loss, US$1.06 million in operating cash outflows and net liabilities of US$46.91 million. Management says the company’s ability to continue as a going concern depends on developing Bau, securing potential Quantum funding and resolving its mining tenure and regulatory issues.
Maxwell Dee
Maxwell Dee
16 Nov 2026
Amari Metals Australia has launched a NZ$1.65-per-share cash offer for Metro Performance Glass, valuing control at a 64.2% premium to the last NZX close. Its existing 51% shareholder lock-up makes the acceptance threshold largely academic, but the path to a full delisting still depends on minority holders and outstanding offer conditions.
Victor Sage
Victor Sage
16 Nov 2026
Western Gold Resources has signed a 30-month ore purchase agreement with Forrestania Resources covering up to 1.1 million tonnes from its Gold Duke Project. The deal opens a potential path to production and cash flow, but haulage costs, plant availability and an updated mine plan still need to be resolved.
Maxwell Dee
Maxwell Dee
13 Nov 2026
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
Genetic Signatures’ proposed Microba merger faces a formal challenge from 18.46% shareholder BCAL Diagnostics, which alleges the process lacks adequate protections and information for GSS investors. The Takeovers Panel has not yet appointed a sitting Panel or decided whether to open proceedings.
Ada Torres
Ada Torres
13 Nov 2026
OpenLearning has secured a $500,000 investment from Philippine conglomerate World Citi Group, lifting commitments to its capital raising to approximately $1.48 million. The deal adds a potential technology partnership to a funding effort backed by record SaaS growth, but the larger entitlement offer still depends on shareholder participation.
Sophie Babbage
Sophie Babbage
13 Nov 2026
Wide Open Agriculture has secured a $1 million placement to fund manufacturing trials, commercial development and working capital as it targets a return to lupin ingredient production in Q2 2027. The raise strengthens its cash position, but production still depends on selecting a partner and completing technical validation.
Victor Sage
Victor Sage
13 Nov 2026
Neurizon’s first participant in the 250-person Regimen I ALS trial has completed the 36-week randomised phase and entered an optional active treatment extension. The milestone keeps the program on track for topline results in late Q2 2027, while recent FDA feedback points to a potential single-trial approval pathway if the data meet regulatory standards.
Ada Torres
Ada Torres
13 Nov 2026
Bass Oil delivered a stronger October, with group production up 28% to 13,146 barrels and revenue rising 8.3% to A$1.83 million. Bunian 6 is exceeding expectations, while Vanessa remains on track for first gas sales by year end, subject to approvals and remaining site work.
Maxwell Dee
Maxwell Dee
13 Nov 2026
Big River Industries has agreed to a $1.62-a-share cash scheme with CTL, valuing its equity at approximately $156 million and securing support from shareholders controlling 59.5% of the register. The deal remains conditional on ACCC, Court, independent expert and shareholder approvals, with completion targeted for early 2027.
Victor Sage
Victor Sage
13 Nov 2026
Kincora Copper has used a US$10 million Mongolian asset sale and AngloGold Ashanti-backed exploration to broaden its New South Wales copper-gold portfolio. The quarter ended with approximately A$13 million in cash, but the unaudited accounts still flag material uncertainty over ongoing funding.
Maxwell Dee
Maxwell Dee
13 Nov 2026

Browse the archive

Full archive